MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41408-025-01293-x

Медицинская библиотека · Blood cancer journal · 2025

Outcomes of acute myeloid leukemia with KMT2A (MLL) rearrangement: a multicenter study of TROPHY group.

Zhang Ruoxuan, Huang Huihong, Zhang Yi, Xia Yi, Huang Jiayu, Jiang Chuanhe, Wang Luxiang, Lu Haiyang, Pan Zengkai, Wang Gaoxiang, Yang Yang, Ma Yilei, Mo Xiaodong, Shi Wei, Hu Xiaoxia, Cao Yang

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

Acute myeloid leukemia (AML) with KMT2A rearrangement (KMT2A-r) is associated with poor prognosis, but the benefit of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for KMT2A-r AML is unclear. We reviewed adult AML patients treated within the TROPHY group and identified 292 cases of KMT2A-r AML, 254 (87.0%) of whom achieved first complete remission (CR1) and 192 (75.6%) of CR1 patients underwent allo-HSCT. We show that allo-HSCT is an independent favorable prognostic factor in CR1 patients for both overall survival (OS) (hazard ratio [HR] = 0.56, 95% confidence interval [CI]: 0.45-0.69, P < 0.001) and cumulative incidence of relapse (CIR) (HR = 0.01, 95% CI: 0.005-0.04, P < 0.001). Among allo-HSCT recipients, survival outcomes were comparable between patients with KMT2A::MLLT3 and those with other 11q23/KMT2A rearrangements (3-year OS: 74.3% vs. 77.5%, P = 0.97; 3-year event-free survival [EFS]: 55.2% vs. 62.2%, P = 0.34; 3-year CIR: 24.4% vs. 20.8%, P = 0.32). Both multiparameter flow cytometry-based measurable residual disease (MFC-MRD) and KMT2A-r MRD determined by quantitative PCR prior to allo-HSCT were associated with worse transplant outcomes. Multivariable analysis identified detectable KMT2A-r MRD at allo-HSCT as a significant risk factor for reduced EFS (HR = 2.46, 95% CI: 1.32-4.60, P = 0.005). These findings confirm the survival benefit of allo-HSCT in adult patients with KMT2A-r AML and underscore the prognostic value of KMT2A-r MRD prior to transplantation.

Для цитирования: Zhang Ruoxuan, Huang Huihong, Zhang Yi, Xia Yi, Huang Jiayu, Jiang Chuanhe, Wang Luxiang, Lu Haiyang, Pan Zengkai, Wang Gaoxiang, Yang Yang, Ma Yilei, Mo Xiaodong, Shi Wei, Hu Xiaoxia, Cao Yang. Outcomes of acute myeloid leukemia with KMT2A (MLL) rearrangement: a multicenter study of TROPHY group.. Blood cancer journal. 2025. DOI: 10.1038/s41408-025-01293-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.